Wearable-Derived Digital Biomarkers for Predicting Systemic Therapy Toxicity and Survival in Oncology.

Wearable sensors continuously tracking activity and heart rhythms can predict chemotherapy side effects better than clinic visits alone.

Systematic review of wearable-derived digital biomarkers (activity, heart rate variability, sleep, respiratory rate) demonstrates their emerging utility for predicting chemotherapy toxicity and survival in oncology patients, with continuous passive monitoring providing superior granularity over episodic clinic-based assessments.

What the study was

Study design

review

Category

novel_therapeutics

Maturity

emerging

Journal

Critical Reviews in Oncology/Hematology

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.